ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,14647
0,17%
Bitcoin
61.194,64
0,65%
Brent Oil
82,43
-0,19%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Avalo Therapeutics Inc (AVTX)

  7. Avalo Therapeutics Inc (AVTX) Notícias

AVTX

Avalo Therapeutics (AVTX)

Avalo Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVTX
DataHoraFonteTítuloCódigoCompanhia
02/04/202408:00GlobeNewswire Inc.Avalo Therapeutics Appoints Biotech Leaders to Board of DirectorsNASDAQ:AVTXAvalo Therapeutics Inc
29/03/202417:01GlobeNewswire Inc.Avalo Reports 2023 Financial Results and Provides Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
27/03/202417:01GlobeNewswire Inc.Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 MillionNASDAQ:AVTXAvalo Therapeutics Inc
14/02/202423:13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVTXAvalo Therapeutics Inc
31/01/202418:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
27/12/202309:00GlobeNewswire Inc.Avalo Therapeutics Announces 1-for-240 Reverse Stock SplitNASDAQ:AVTXAvalo Therapeutics Inc
21/12/202318:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTXAvalo Therapeutics Inc
07/12/202309:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AVTXAvalo Therapeutics Inc
07/12/202309:00GlobeNewswire Inc.Avalo Encourages Stockholders to Vote FOR the Reverse Stock SplitNASDAQ:AVTXAvalo Therapeutics Inc
09/11/202309:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVTXAvalo Therapeutics Inc
09/11/202309:00GlobeNewswire Inc.Avalo Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
31/10/202308:00GlobeNewswire Inc.Avalo Completes Divestiture of AVTX-800 SeriesNASDAQ:AVTXAvalo Therapeutics Inc
19/10/202317:15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AVTXAvalo Therapeutics Inc
19/10/202317:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AVTXAvalo Therapeutics Inc
05/10/202317:02Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AVTXAvalo Therapeutics Inc
26/09/202308:00GlobeNewswire Inc.Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and InnovationNASDAQ:AVTXAvalo Therapeutics Inc
12/09/202308:00GlobeNewswire Inc.Avalo Enters into Agreement to Divest AVTX-800 SeriesNASDAQ:AVTXAvalo Therapeutics Inc
06/09/202308:00GlobeNewswire Inc.Avalo to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AVTXAvalo Therapeutics Inc
07/08/202318:26Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AVTXAvalo Therapeutics Inc
03/08/202308:00GlobeNewswire Inc.Avalo Reports Second Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
06/07/202317:01GlobeNewswire Inc.Avalo to Participate in SVB Securities Therapeutics ForumNASDAQ:AVTXAvalo Therapeutics Inc
29/06/202309:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVTXAvalo Therapeutics Inc
28/06/202319:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVTXAvalo Therapeutics Inc
28/06/202307:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AVTXAvalo Therapeutics Inc
26/06/202308:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVTXAvalo Therapeutics Inc
26/06/202308:00GlobeNewswire Inc.Avalo Announces Topline Data from Phase 2 PEAK Trial for AVTX-002 (quisovalimab) in Patients with Non-Eosinophilic AsthmaNASDAQ:AVTXAvalo Therapeutics Inc
01/06/202308:00GlobeNewswire Inc.Avalo to Present at the Jefferies Healthcare ConferenceNASDAQ:AVTXAvalo Therapeutics Inc
22/05/202308:00GlobeNewswire Inc.Avalo Announces Appointment of Michael Croft, Ph.D. and Jeff Edelson, M.D. to its Scientific Advisory BoardNASDAQ:AVTXAvalo Therapeutics Inc
15/05/202308:00GlobeNewswire Inc.Avalo to Present at ATS 2023 Respiratory Innovation SummitNASDAQ:AVTXAvalo Therapeutics Inc
10/05/202308:00GlobeNewswire Inc.Avalo to Present at the 2023 RBC Capital Markets Global Healthcare ConferenceNASDAQ:AVTXAvalo Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVTX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BHIA3
Grupo Casas Bahia ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PETZ3
Pet Center Comercio E Pa... ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
GUAR3
GUARARAPES ON
BOV
TELB4
TELEBRAS PN
BOV
LREN3
LOJAS RENNER ON
BOV
IDIV
Dividend
BOV
PETR4
PETROBRAS PN
BOV
GOLL4
GOL PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados